Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FiESTAA: Escitalopram in Adolescents with Anxiety
NCT02818751Completed
- Sponsor
- University of Cincinnati
- Start
- May 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of escitalopram in generalized anxiety disorder (GAD) (3 arms), sponsored by University of Cincinnati. Primary endpoint: Early escitalopram-related functional brain activity changes during emotional processing at 2 weeks. Started May 2015; status: completed.
02
Drugs
escitalopram
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT02818751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818751.